Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

HCCC + Mission: A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigators Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)

Holden Comprehensive Cancer Center

Cancer Internal Medicine Leukemia Lymphoma Adult Subjects Male Subjects Female Subjects

Principal investigator

Grerk Sutamtewagul

Internal Medicine

View other research studies by Grerk Sutamtewagul

Participate in this trial

Are you interested in enrolling in this study? Learn more here.

I'm Interested In Participating